Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Ira Zackon sat down with Oncology Data Advisor to discuss his abstract regarding real-world treatment patterns and survival outcomes among patients with myelodysplastic syndromes (MDS), including ways for making clinical trial data applicable for patients treated in the community oncology setting.  

Continue reading

Copyright © Oncology Data Advisor. All rights reserved.